Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.98
+0.16 (1.63%)
Jun 10, 2026, 3:01 PM EDT - Market open
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$552,270
Profits / Employee
-$423,989
Market Cap
792.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | -56 | -13.11% |
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Kura Oncology | 260 |
| Sana Biotechnology | 142 |
| Alpha Tau Medical | 121 |
| Cullinan Therapeutics | 109 |
| ORIC Pharmaceuticals | 104 |
| Inventiva | 77 |
| Alto Neuroscience | 68 |
PHAT News
- 1 day ago - Phathom Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 7 days ago - Phathom Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 15 days ago - Needham pharmaceuticals analysts hold analyst/industry conference call - TheFly
- 19 days ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals reports Q1 non-GAAP EPS (18c), consensus (19c) - TheFly
- 5 weeks ago - Phathom Pharmaceuticals still sees 2026 revenue $320M-$34M, consensus $332.04M - TheFly